Kudzokera kumashure kwevakadzi: science
Zvirwere zvakawanda zvinouraya vanhu zvine chikonzero chimwe chete: kushaya simba. Pakutanga, vatsvakurudzi vakakwanisa kumisa kushaya simba kwevanhu nenyama uyewo kubvisa zvimwe zviratidzo zvacho mumuviri wemunhu. Hapana chinhu chatinogona kuita kuti tigadzirise dambudziko iri, asi chokwadi ndechekuti chirwere ichi chiripo uye chinotanga kupararira nekukurumidza.
Snuupo / Wikimedia Commons (CC BY-SA 4.0)
Munguva dzekare, vanhu vaifa vadiki nekuda kwechirwere, kusvibiswa uye kuzvarwa. Nhasi, muchikamu chikuru chepasi rose, vanhu vanofa vachiri vadiki, uye vanofa nechirwere chinotadza kupararira: chirwere chemoyo, chirwere cheshuga, chirwere chegomarara, chirwere chepfungwa, chirwere cheshuga uye chirwere chemapfupa. Kana munhu akafa, anopiwa mari yechiremba wake, chikafu, uye mishonga. Asi vane imwe chete yakakura kwazvo yekuwedzera, uye haisi kusvibiswa kweropa, kudya kana hunhu. Inguva. Kukura kwesainzi, inonzi geroscience, kunobvunza mibvunzo mishoma: sezvatisingazvipinde nechirwere chepakutanga chete, tingaitei kuti tirambe tichiramba tichikura? Iyi peji inotaura, zvakajeka uye zvakarurama sezvatinogona, kuti izvi zvinoratidzwa sei neongororo iyi, zvipi zvazvisina kuratidzwa, uye kuti zvinogona kuita sei kwatiri.
Nei kukura kwevanhu kuri kuwedzera kukonzera chirwere cheshuga
Ona chero chirwere chinotambura nemakore uye chinoratidzawo kuti: chinowanzoitika muvadiki, asi ichikwira zvakanyanya nemakore. MuUnited States muna 2025, pamusoro 0.5 muzana yevanhu vakura makore 18 kusvika 44 aiva nguva dzose akawanikwa ane coronary moyo chirwere; pakati pevanhu vane makore 75 uye kupfuura yakanga 19 muzana. Any cancer: 2 percent against 33 percent. Arthritis: 6 muzana ne53 muzana (NCHS, NHIS 2025). New cancer diagnoses rinobva pamusoro 236 per 100,000 vanhu gore pamakore 40 kusvika 44 kuti pamusoro 2,400 pa 80 kusvika 84 (NCI SEER). Kunyanya vanhu vari pasi pemakore 65, huwandu hwevanhu vari kurwara nechirwere ichi hunowedzera kaviri pagore kusvika pakusvika mumwe muzana wevanhu vane makore 90 kana kupfuura.Manly et al., 2022).
MuUS data pamusoro, coronary chirwere chemoyo ndezve 38 nguva sezvinoitika pa 75 uye kupfuura sepa 18 kusvika 44. Izvi ndizvo zvakaita kuti nyanzvi dzehutano dzipinde munyaya yekuti vanhu vakura sei, vachiti “izvi ndezvekukonzera chirwere chikuru chinokonzeresa chirwere cheshuga” uye kuti kuongororwa kwevanhu vakakura kunotibatsira sei kuti tirambe tiri pahupenyu hwakanaka.Kennedy et al., 2014). Chii chinonzi geroscience? Iine zvikonzero zvekushandisa. Kurapa chirwere chepakutanga chinowedzera upenyu hwakawanda, asi vamwe vari kumirira: vanhu vakachengetwa kubva pamoyo vanotanga kurwara nekanzera, dementia kana stroke makore mashoma gare gare. Kuderedza kuora mwoyo kunozozvibata zvese zvakadzokera kumashure pamwechete.
Vachiremba vakaedza kuisa mari panyaya iyi. Muongororo wakaitwa mu2013 kuUS yakaratidza kuti kana vanhu vakarasikirwa nemakore akawanda, vanokwanisa kuramba vachirarama kwemakore 2.2, uyewo vari pahutano hwakanaka, izvo zvinoda mari inosvika $7.1 trillion pamusoro pemakore 50 (Goldman et al., 2013). Kudzidza kwe2021 kwakafungidzira kuti kunonoka kwekukura kwakakwana kuwedzera gore rimwe rehupenyu hwakareba zvichave zvakakwana $38 trillion to the US, and ten years $367 trillion (Scott, Ellison neSinclair, 2021). Izvi ndezvemamodeli akavakwa pazvinhu zvakajairika, asi zvinoratidza kuti nei magovera nevanoita mari vachipa pfungwa dzavo.
Chii chinogona kuitika: zviratidzo zvekukura kwevanhu
Kukura kwevanhu hakusi imwe nzira asi mimwe, inoitika pamwe chete uye ichibatsirana. Mu 2013 timu yakatungamirirwa naCarlos López-Otín yakavaunganidza muzvina pfungwa dzekukura, uye mu2023 yakakanganisa runyorwa rwemazana maviri (López-Otín et al., 2013; López-Otín et al., 2023). Mumashoko akajeka:
- Genomic instability: dambudziko reDNA rinowedzera nekukurumidza kupfuura zvarinogadzirirwa.
- Telomere attrition: zvinodzivirira zvipfeko pamadziro echromosomes zvinovhara pasi.
- Epigenetic zvikonzero: zvekemikari marks kuti switch genes pamusoro uye off drift kunze yavo youthful pattern.
- Kurasikirwa neproteostasis: mapuroteni anozvibata zvakaipa uye anotambanudza pamwe chete.
- Disabled macroautophagy: chigadzirwa cheiyo cell’s recycling system chinononoka.
- Deregulated nutrient sensing: kukwira masignals semuenzaniso mTOR uye insulini kumira wakaiswa pashure apo kudzoreredza zvaizoita zvakanaka.
- Mitochondrial dysfunction: simba remagetsi re cell rinoita mashoma emagetsi uye zvigadzirwa zvinokuvadza.
- Cellular senescence: zvakakuvadzwa muviri kubvisa kuparadzana asi vanobvuma kufa, uye kuburitsa inflammation mapoinzi.
- Stem cell exhaustion: zviwanikwa zvinogadzirisa tishu zvinomira.
- Alterated intercellular communication: masimba pakati pezvirwere uye mishonga inoitika zvakaipa.
- Chronic inflammation: a low, constant inflammation, sometimes called “inflammageing”.
- Dysbiosis: kugadzikana kwemicrobes muzvipfuwo zvinochinja.
Nekuti zvose zvinotaurwa pawebhusaiti ino zvinotarisana neimwe kana zvakawanda dzezviratidzo izvi. Zvinodiwa zvemufananidzo ndezvekuti: inofanira kuonekwa nemakore, ichiwedzera nguva yacho, inofanira kuwedzera nguva yekukura kwayo, uye ichiideredza nguva yake, inofanirwa kuwedzera nguva yekukura kwayo. Chimwe chezvikonzero nei pfungwa iyi ichishandiswa zvakanyanya ndechekuti, kune vamwe vanhu, kuongorora kwevanhu kunoda nguva yakareba kupfuura kuongorora kwenyama.
Tinoziva sei? An evidence scale
Chirevo “anti-ageing” chinotaura nezvezvose kubva kune zviito zvakaratidza kubudirira muvanhu vanopfuura mamiriyoni maviri kusvika kune zviito zvakaongororwa nemunhu mumwe chete. Kuti tichengete zvakasiyana, chero nzira pane iyi peji inotakura imwe yemhando mbiri:
- Yakaratidza muvanhu: dzidzo huru dzevanhu uye kuongororwa kwaka randomized zvinoratidza zvishoma chirwere uye kufa.
- Kuedza kwevanhu kunopa chivimbo: kuongororwa kwakaitika muvanhu zvinoratidza kuti zvinoita basa, asi hazvisizvo panyaya yekukura kwevanhu.
- Strong in animals: yakapetwa, yakasimba mikana muzvinyama; vanhu chokwadi chidiki, zvakasiyana kana chete kutangira.
- Early kana speculative: yakaderera, yakapikisana kana imwe-yekudzidza chokwadi, kana kuedza kwevanhu kusvika parizvino zvakanyanya pasina chikonzero chakajeka.
Kuti zvive pachena: hapana chinhu paiyi peji chakaratidzwa kuti chinoderedza kana kudzosera hupenyu hwevanhu sechinhu chega. Hapana chiremba, chikafu kana chiremba wegene anobvumidzwa kurapa hupenyu hwevanhu chero kupi pasi rose. Saka nei vakazvipira vatsvakurudzi vachifara? Nekuti makore makumi maviri apfuura hapana munhu aigona kuvimbisa kusimudzira hupenyu hwenyama inorarama neropa, uye zvino mishonga yakawanda inoita izvi, muzvidzidzo zvakaomarara mumalaboratories akasiyana-siyana; nekuti ma cell akawandisa anogona kuita kuti aite sezvinoita vana vechidikizve mumvura yekudya uye, muzvimwe zvirwere, muzvipfuwo; uye nekuti zvinotarisirwa kuti vanhu vatsva vaone biology yekukura kwevanhu, kwete chirwere chimwe chete. Kufamba kubva panyama kuenda kumunhu kunotora nguva yakareba, uye mikana yakawanda inotarisirwa haisi kuitika. Asi chinangwa chacho chinoratidzika pachena.
Kuziva zvinhu zvinovaka muviri: mTOR nerapamycin
Evident grade: kuvimbisa ongororo dzevanhu
Chii chinonzi? Kana muviri wako uchida kurarama, unofanira kuita zvinhu zviviri: Kukura kana kuti kubvisa. A protein complex called mTOR (The mechanistic chinangwa rapamycin) inoita kuti kufona: kana kudya uye kukura zviratidzo vari akawanda, mTOR inoti “kura”; kana vachiri vashoma, inodzokera kumashure uye cell switches kune maintenance, kusanganisira rekudzokorora yayo yakadzingwa zvinhu kuburikidza autophagy. Panguva yepakutanga, mTOR inoramba ichishanda kupfuura zvainoda kuti iite. Kudzokera pasi ndeimwe yenzira dzakaomarara dzekuwedzera hupenyu hweyeast, maworms, fly uye mouse.
Rapamycin ichirimwa chinonzi chinodzivirira mTOR. Yakawanikwa mumufananidzo wevhu kubva kuRapa Nui (Island yePasi), iyo yakapa zita rayo, uko inogadzirwa nebacteria, Streptomyces hygroscopicus (Vézina, Kudelski and Sehgal, 1975). Pazviyero zvakakwirira zvashandiswa kwemakore akawanda kuti zviite kuti muviri usabvumire kusvibiswa kwemararamiro.

Muzvinyama. Mu 2009 US National Institute on Aging’s Interventions Testing Program, iyo inoongorora zvinhu mumishonga yemuromo yakasiyana-siyana nemhando dzakasiyana dzemishonga palaboratories matatu panguva imwe chete, yazivisa kuti rapamycin yakawedzera upenyu hwemunhu kunyange kana ichipihwa pazuva re600, risati rasvika pakukura kwemuromo. Kutanga pazera iri, kutarisirwa kwehupenyu kwakakwira ne28 muzana muvakadzi uye 38 muzana muvarume (Harrison et al., 2009). Pakuwedzera kwedosi rakatangira mumakore epakati, hupenyu hwehupenyu hwakakwira ne23 muzana muvakadzi uye 26 muzana muvarume (Miller et al., 2014). Rapamycin ndiyo chete mishonga inoshandiswa mumishonga iyi inoshanda zvakasimba pavanhu vaviri, uye iriwo mishonga ine simba kwazvo rekusimudzira hupenyu hwemamamiriro ekunze.
Muvanhu. Mumwe munhu muenzaniso ndewechokwadi asi zvishoma. In a randomised trial in older volunteers, six weeks of everolimus, a close relative of rapamycin, improved the response to a flu vaccine by about 20 percent (Mannick et al., 2014), and a later trial of a related combination reduced infections over the following year (Mannick et al., 2018). But a larger phase 3 trial of a similar drug, in more than 1,000 older people, found no reduction in respiratory illness (Mannick et al., 2021). PEARL trial yakapa vanhu vane hutano vadiki madosi e rapamycin kwevhiki imwe chete kwemazuva 48. Hapana chaakachinja chiyero chayo chekutanga, visceral fat, uye zviratidzo zvepamberi zvakafanana neplacebo; zvimwe zvepamusoro zvinodiwa, senge masimba emakumbo evanhukadzi pakuwedzera kwedosi, zvakavandudzwa (Moel et al., 2025). Kuongorora kwe2024 kwe19 dzidzo hakuone chero zvakaipa zvinokonzerwa nehutano hwevanhu, asi zvimwe zvirwere uye zvishoma zveropa muvanhu vakange vaine hutachiona hwakafanana nehupenyu (Lee, Kuerec and Maier, 2024).
Risks. At transplant doses, rapamycin suppresses the immune system and carries warnings about serious infections and some cancers. Muromo ulcers, kukwira cholesterol uye triglycerides, slower kurapwa kweropa uye fluid build-up ndezvimwe zvemhedzisiro (US FDA sirolimus label). Mumishonga, kushandiswa kwenguva refu kunokonzerawo kuoma kweinsulini (Lamming et al., 2012). Vatsvakurudzi vari kuedza nhamba shoma uye dzakasvibiswa dzezvirwere, pamwe nezvinodhaka zvitsva zvinorambidza chete chikamu chemTOR chinokonzera hupenyu hwakareba.
Senolytics: kubvisa “zombie” macell
Evident grade: strong in animals
Chii chinonzi? Kana muviri wemunhu uchikuvadzwa zvakaipa, unogona kusangana nemamiriro anonzi senescence: unomira kuparadzana, izvo zvinodzivirira kubva kune cancer, asi haufarire. Senecious selula dzinova nemakore. Zvakaipa, ivo kuburitsa cocktail yeinflammatory masimba, senescence-inobatanidza secretory phenotype (SASP), iyo inokuvadza zvakachengeteka macells pamusoro pavo (Coppé et al., 2008). Senolytics zvinonzi majekiseni anoshandiswa kuuraya chirwere cheshuga.

Muzvinyama. Mu2011, vatsvakurudzi vakagadzira maminetsi emhando yepamusoro kuti hupenyu hwavo hwese hunogona kugadziriswa pavanoda. Kubvisa kwavo kwakaderedza kukuvadzwa kwepamuviri mufashoni, mishonga uye maziso (Baker et al., 2011). Muzvipfuyo zvakajairika, kubvisa izvi zvirwere kubva kumashure kwemakore akapetwa ne24 kusvika 27 muzana (Baker et al., 2016). Iyo yekutanga senolytic drug combination, dasatinib pamwe quercetin, yakawanikwa mu2015 (Zhu et al., 2015). Yakapihwa kune vanhu vadiki kwazvo, yakavandudza muviri webasa uye yakawedzera kurarama kwehupenyu ne36 muzana (Xu et al., 2018). Fisetin, a natural compound found in strawberries, extended lifespan when given to old mice (Yousefzadeh et al., 2018).
Muvanhu. The first human results are small and mixed. Muvanhu 14 vane hutachiona hwepafu, idiopathic pulmonary fibrosis, zvitatu zvemasvondo edasatinib plus quercetin zvakavandudza kufamba kwekufamba uye kumhanya, kunyangwe hazvo kwete kutenderera kweropa, mubvunzo pasina placebo group (Justice et al., 2019). Muvanhu vasere vane chirwere cheshuga cheshuga, mishonga yakaderedza senescent cells mufashoni uye muviri uye yakaderera inflammatory signals muropa (Hickson et al., 2019). Asi mubvunzo wakatorwa nevanhukadzi vane makore 60, mishonga iyi yakaratidza kuti haisi kuvandudzwa kwemapfupa; chete varume vane macells ane makore akawanda vakaona kuti vanowana mari (Farr et al., 2024). Mudzidzo yekuita muvanhu vashanu vane chirwere cheAlzheimer, dasatinib yakasvika mukutenderera kwepfungwa asi quercetin haisi (Gonzales et al., 2023). Mazhinji fisetin bvunzo paMayo Clinic iri kuenderera mberi (ClinicalTrials.gov NCT03675724).
Iyo yekutanga kambani yakavakwa pamusoro pesenolytics, Unity Biotechnology, yakati iongorore inouraya maziso, UBX1325 (foselutoclax), yechirwere chemaziso chediabetic. Mushure mekukurudzira kuedza kwekutanga, kuwedzera kwechikamu che2 chekuongorora ichienzanisa nechirongwa chekurapa chakasiya chinangwa chayo chakakosha (Unity Biotechnology, 2025), uye kambani yakaparadzwa mushure megore iro (SEC filing, 2025).
Risks. Dasatinib ichiri chiremba chekanzera nematambudziko ekunze, kusanganisira zvikonzero zvekushaya mvura muropa. Senescent selulawo vane mabasa anokosha, semuenzaniso pakurapa zvirwere, saka kubvisa kwavo hakusi pasina njodzi.
NAD +, NMN uye NR
Evident grade: yakatanga kana speculative
Chii chinonzi. NAD + ndeimwe yemamolecule ezvidiki izvo zvese zvikamu zvinoda kushandura kudya kuita simba uye kugadzirisa DNA. Zviyero zvayo zvinodzikira nemakore muzvirwere zvakawanda. Mamwe maprecursors ayo muviri anogona kushandura kuita NAD +, nicotinamide mononucleotide (NMN) uye nicotinamide riboside (NR), anotengeswa sezvipfuwo.
Muzvinyama. Mumishonga, gore reNMN mumvura yekunwa yakagadzirisa akawanda shanduko dzinokonzerwa nemakore, kusanganisira kukwira kwehuremu uye kudzikira kwekushandisa simba (Mills et al., 2016), uye NR yakavandudza mitochondrial uye stem cell function uye yakawedzera zvakanyanya upenyu hwevanhu vadiki (Zhang et al., 2016). Asi apo Interventions Testing Program yakaongorora NR neyakaomarara dhizaini, haisi kusimudzira huremu hwehupenyu mune chero chiito (Harrison et al., 2021).
Muvanhu. NR neNMN zvinowedzera zvakachengeteka NAD + muropa (Martens et al., 2018). Iyo yakanyanya kuzivikanwa yakajairika bvunzo yakapa NMN kune 25 vakadzi vane prediabetes kwemakumi maviri evhiki: kugadzikana kweinsulin yemuscle kwakavandudzwa ne25 muzana, asi chirwere cheropa, mafuta eropa uye kuumbwa kwemuviri hakuchinja (Yoshino et al., 2021). Mudiki bvunzo muchirwere cheParkinson, NR akawedzera NAD mupfungwa neyakajeka chiremba kuvandudzwa (Brakedal et al., 2022); kuwedzera bvunzo yakati wandei yakapera uye zvidzidzo zvayo zvinotarisirwa. Kuongorora kuti pool kuedza kusvika parizvino kuwana zvipfuwo zvakachengeteka munguva pfupi asi nevamwe hapana chiratidzo chakakosha kubatsira glucose muviri, muviri mafuta kana mishonga (Zhang et al., 2025; Prokopidis et al., 2025). Chii hachiratidzwe: kuti kusimudzira NAD + kunoderedza hupenyu hwevanhu kana kubvisa chero chirwere muvanhu.
Regulation. Mu2022, US Food and Drug Administration yakataura kuti NMN haigone kutengeswa sekudya kwekudya nekuda kwekuti yaive ichidzidza sechiremba; muna Zvita 2025 yakachinja iyo maonero (FDA, 2025). Kuve pakutengesa inoti hapana nezve kana chigadzirwa ichishanda.
Sirtuins uye resveratrol nyaya
Evident grade: yakatanga kana speculative
Chii chinonzi. Sirtuins ndeimwe yemhuri ye enzymes, makumi mana mumamiriro ezvinhu, ayo anoshandisa NAD+ kudzora DNA yekudzoreredza, metabolism uye gene activity. Mu 2003, ongororo yakazivisa kuti resveratrol, a compound yakawanikwa mu red grapes, akavhura sirtuin uye akawedzera upenyu hweyeast (Howitz et al., 2003). Mu 2006 resveratrol yakawedzera hutano uye kurarama kwemazino pa high-calorie kudya (Baur et al., 2006). Mu 2008, GSK yakatenga Sirtris, kambani inogadzira sirtuin activators, yemadhora anenge 720 miriyoni (GSK uye Sirtris, 2008).
Zvino yakanga yakafa. Nyaya iyi haisi kutevedzera zvakanaka. Resveratrol haana kusvikira hupenyu hwemaminetsi ezvipfuyo zvakajairika pakudya (Pearson et al., 2008), kusanganisira muInterventions Testing Program (Miller et al., 2011). Biochemists vakawana kuti zvakajeka kumisikidza kwayo kweSIRT1 sirtuin yaive yakatarisana neyakagadzirwa fluorescent tag yakashandiswa mubvunzo (Kaeberlein et al., 2005; Pacholec et al., 2010). Nekuti zvakajairika hupenyu hwehupenyu hwekuwedzera sirtuin muzvirwere uye mabhureki zvakanga zvadzikira zvakanyanya kana genetic backgrounds yakanyatso kudzorwa (Burnett et al., 2011).
What remains credible. Sirtuins still matter. Mishonga yakagadzirwa kuti iite zvakawanda zvemumwe sirtuin, SIRT6, yaive nehupenyu hwakareba: mukadzi chete mukutanga dzidzo (Kanfi et al., 2012), uye mune imwe yekupedzisira dzidzo 27 muzana yakareba median hupenyu muvakadzi nevarume uye 15 muzana muvarume, nekuwedzera kwehutachiona (Roichman et al., 2021). Chii chinonzi genetics, kwete pill. No sirtuin-activating zvipfuwo zvakaratidzwa kuti kuwedzera kwemakore muvanhu.
Telomeres uye telomerase
Evident grade: yakatanga kana speculative
Chii chinonzi. Telomeres ndezvimwe zvemasimba eDNA ayo anowedzera kana kuchinja zvikamu zvechromosome yedu, sezvinoita mabhureki ekushongedza. Vachakurumidza kuderera pavanoparadzana; kana vachiita kuti vaite sekuti vari vadiki, muviri wemunhu unomira kuparadzana kana kuti anofa. An enzyme called Telomeres anogona kuvakwazve. Elizabeth Blackburn, Carol Greider uye Jack Szostak vakabatanidzwa mu2009 Nobel Prize muPhysiology kana Medicine yekutsvaga kuti sei izvi zvinoshanda (Nobel Prize, 2009).

Muzvinyama. Mu2012, nyanzvi dzemuSpanish National Cancer Research Center dzakapa midzi yakakura mushonga wegene uyo wakachinja telomerase kuti iite basa rayo. Median hupenyu hwaive ne24 muzana mumidzi yakagadziriswa pagore rimwe chete uye 13 muzana mumidzi yakagadziriswa pamakore maviri, pasina kukwira kwechirwere (Bernardes de Jesus et al., 2012). Izvi zvinoramba zvichireva kuti hapana chikonzero chekuzviisa pasi.
The cancer problem. Cancer cells need to divide without limit, and most of them do it by switching telomerase on: in a landmark study, 90 of 101 tumour samples had telomerase activity, and none of 50 normal tissues did (Kim et al., 1994). Vanhu avo magene anovapa telomeres akareba vane kuwedzera kwechirwere chemoyo asiwo kukonzera chirwere cheshuga, gliomas, adenocarcinoma yepamuviri uye melanoma (Haycock et al., 2017). Telomeres pfupi hazvisi chete “zvakaipa” uye zvose “zvakanaka”.
Muvanhu. Zvimwe zvirwere zvakadai sedyskeratosis congenita zvinokonzerwa nematambudziko e telomerase uye zvinogona kukonzera chirwere cheshuga yeropa, kurwadziwa kwepamuviri uye kufa kwakaoma.Armanios uye Blackburn, 2012). Mubvunzo muzviremba, hormone danazol akawedzera telomeres mu11 ye12 vanhu vaigona kuongororwa (Townsley et al., 2016). Chirwere ichi chine chirwere chinoitika kakawanda, asi hachikonzere kuora mwoyo. Kuzvipira ye chero mashoko kuti chigadzirwa kana kliniki “inowedzera telomeres yako” kuti iwe uite uchikura: mu2015 mukuru wekambani imwe akati aive akagamuchira telomerase gene therapy kunze kwenyika, asi mapepa haasi kunyatsoongororwa mune peer-reviewed study (MIT Technology Review, 2015).
Kugadzirisa kwechinguvana neYamanaka factors
Evident grade: strong in animals, first human trial underway
Chii chinonzi? Mu 2006 Shinya Yamanaka akaratidza kuti kuchinja kweanenge maviri chete emhando dzemagene, ayo anonzi Yamanaka factors (OCT4, SOX2, KLF4 uye c-MYC, kana OSKM), anoshandura muviri wemunhu wepakutanga kuita muviri we embryo-yakaita stem cell iyo inogona kuve chero mhando yechigadzirwa che cell (Takahashi and Yamanaka, 2006). Akawana mu2012 Nobel Prize for Physics.Nobel Prize, 2012). Panzira, makore e cell anobvisa: makemikari emazita paDNA ayo anodzokera kurudziro yevadiki. Chii chinonzi partial reprogramming ndechokuti tiite zvinhu izvi chete kwenguva pfupi, nguva yakareba zvakakwana kuti tidzosere zviratidzo zvemakore asi kwete nguva yakareba zvakakwana kuti muviri urege kuziva zvazvinoreva.

Muzvinyama. Mu2016, maminetsi ayo achiri kukura zvakapihwa OSKM mumigwagwa, mazuva maviri nemakumi mana ezuva. Masimba avo akaratidza zviratidzo zvakaderera zvekukura uye vakararama kwenguva yakareba (Ocampo et al., 2016). Mu 2020, matatu ezvikonzero (OSK, kubvisa c-MYC inobatanidza katsi) yakapihwa kumaziso emazino ane glaucoma-senge kurasika uye emazita emakore, uye akadzosa kuona kwavo nekuisazve mazita paDNA yechiropa chemoyo (Lu et al., 2020). Kuenderera mberi kwenguva refu kwekudzokorora kurongwa muzvipfuyo zvinokura zvakajairika kwakachinja akawanda emolecular markers kuenda kune yakaderera mamiriro (Browder et al., 2022), uye mune imwe ndogo studie, een OSK genetherapie die wordt gegeven aan zeer oude mannelijke muizen dubbeld hun resterende mediane levensverwachting (Macip et al., 2024).

Risks. Kuenda kwakanyanya kunokonzera matambudziko. Panguva iyo zvinhu zvakaiswa pazvirwere zvemuromo, ma cells akarasikirwa nezita ravo uye akaumbwa nematumours anonzi teratomas (Abad et al., 2013); mumwe mubvunzo, kuenderera mberi kweOSKM kwakakonzera hutachiona hwepanyama uye kushaya simba kwechiropa uye kufa mukati mevhiki (Parras et al., 2023). Kudzora dosi, nguva uye kuti ndedzipi zvikamu zvemuviri zvinowana magene aya ndiyo nyaya inonyanya kukonzera dambudziko.
The companies and the first trial. Partial reprogramming has attracted some of the largest investments in biotechnology. Altos Labs launched in January 2022 with $3 billion (Altos Labs, 2022). Retro Biosciences, backed with $180 million by Sam Altman (MIT Technology Review, 2023), works on reprogramming and says its first drug, a pill aimed at cellular recycling, entered a phase 1 trial in 2025 (Retro Biosciences, 2026). NewLimit raised $435 million in 2026 and says it plans a first human trial of a liver therapy (NewLimit, 2026). The first reprogramming therapy to reach people is ER-100 from Life Biosciences, an OSK gene therapy injected into the eye for two diseases of the optic nerve, glaucoma and non-arteritic anterior ischaemic optic neuropathy (NAION). The US Food and Drug Administration cleared the trial in January 2026 (Life Biosciences, 2026), and the first patient was treated in June 2026 in a phase 1 safety study of 18 people (ClinicalTrials.gov NCT07290244; Life Biosciences, 2026). Results will take years. Company announcements are not peer-reviewed evidence, and we will update this page as results are published.
Other serious avenues
Mishonga inowedzera hupenyu hwemuromo
Evident grade: strong in animals
Kubva 2004, Interventions Testing Program yakaongorora 54 compounds muzvipfuyo zvinopfuura 30,000 (Jiang et al., 2025). Chimiro chake chine huremu: imwe cheteyo bvunzo inoitwa muzvitatu zvemalaboratories, nevanhu vane marudzi akasiyana-siyana eganda, saka mubvunzo mumwe nemumwe unowanawo zvibodzwa zvakasiyana. Kunyangwe rapamycin, michina yakawanda yakapfuura: chiremba chechirwere cheshuga acarbose akawedzera 22 muzana kune murume wepakati pehupenyu asi chete 5 muzana kune vakadzi (Harrison et al., 2014); 17-alpha-estradiol, a dhairekitori eestrogen, akawedzera 19 muzana kune varume uye hapana kune vakadzi (Strong et al., 2016); uye chiremba chechirwere cheshuga canagliflozin akawedzera 14 muzana kune varume chete (Miller et al., 2020). Rapamycin yakabatanidzwa neacarbose yakapa kuwedzera kwakanyanya kusvika parizvino: 34 muzana muvakadzi uye 28 muzana muvarume (Strong et al., 2022). Nei mukadzi achiwanawo hutano hwakanaka kupfuura murume, icho chinhu chinokosha. Hapana chezvimwe zvinodhaka izvi zvaraitwa bvunzo dzekuti zvikonzere kuora kwevanhu.

Metformin uye TAME bvunzo
Evident grade: yakatanga kana speculative
Metformin ichiri kushandiswa sechiremba wechirwere cheshuga kwemakore anopfuura makumi masere. A 2014 kudzidza UK hutano mapepa akawana kuti vanhu vane chirwere cheshuga vachitora metformin vakararama zvishoma kupfuura zvakaenzana vanhu vasina chirwere cheshuga (Bannister et al., 2014), izvo zvakaita kuti atungamirire mumiriri weanti-aging chiremba. TAME trial (Targeting Aging with Metformin) yakagadzirwa kuti ione kana ichideredza chirwere chemoyo, chirwere chegomarara, dementia uye kufa pamwe chete muvanhu vakura, uye kuti vabatsire vatungamiriri vezvehutano kuti vaone kushaya simba sechinhu chinogona kukonzerwa nekushandisa mishonga (Barzilai et al., 2016). Sekureva kwaSeptember 2026 isu hatina kuwana chero zvakaburitswa zvibodzwa. Munguva imwecheteyo, nyaya iyi yakaderera: dzidzo yeDanish ine vaviri vakawana hapana kurarama kwakakosha kwevashandisi vemetformin (Keys et al., 2022); metformin chete haisi kusimudzira zvakanyanya hupenyu hwemuromo muInterventions Testing Program (Strong et al., 2016); uye mune maviri ezvidzidzo muvanhu vakuru zvakadzikira mazano ekushandisa kurovedza muviri (Konopka et al., 2019; Walton et al., 2019).
GLP-1 mishonga
Evident grade: kuvimbisa ongororo dzevanhu
Drugs such as semaglutide mimic a gut hormone, GLP-1, and were developed for diabetes and obesity. Mu SELECT kuedza kwe 17,604 vanhu vane obesity uye moyo urombo, semaglutide akaderedza moyo kupararira, strokes uye cardiovascular kufa ne 20 muzana (Lincoff et al., 2023). A study of US veterans with diabetes linked GLP-1 drugs to lower risk of many conditions, including dementia, addiction and infections, and higher risk of others, such as digestive problems and pancreatitis (Xie, Choi uye Al-Aly, 2025), asi izvi observational dzidzo haazokwanisi kuratidza chikonzero. Uye muzvitatu zvakakura zvinoongororwa mukutanga Alzheimer’s chirwere, orally semaglutide akaipa kuderera ([Cummings et al., 2026](https://doi.org/10.1016/S0140-6736(26) 00459-9)). Izvi zvinonyanya kukonzera chirwere cheshuga, asi kana zvave kuita kuti vanhu vagare vari pazera rakaomarara hazvizivikanwe.
Calorie restraint
Evident grade: kuvimbisa ongororo dzevanhu
Kudya zvishoma pasina kushaya kudya kunowedzera hupenyu hwezvisikwa zvakawanda, uye kwaive kwekutanga “anti-ageing intervention” yakawanikwa. Mumapiri, maviri makuru emakore marefu ekudzidza pakutanga akatanga kunge asina kubvumirana, asi imwe yakabatana yekuongorora yakaona kuti kurambidzwa kwecalorie kunovandudza hutano uye kurarama kana zvinyorwa zvekudya uye makore zvichitorwa mupfungwa (Mattison et al., 2017). MuCALERIE 2 trial, 218 vanhu vane hutano, vasina kushaya simba vakabvunzwa kuti vadya 25 percent less kwemakore maviri uye vakakwanisa kudya 12 percent. Huremu hwavo hweropa, cholesterol uye insulin sensitivity yakavandudzwa (Kraus et al., 2019), uye imwe nzira yekuita biological kuora, DunedinPACE, yakaderera ne2 kusvika 3 muzana, kunyangwe mamwe maviri mabhureki asingachinja (Waziry et al., 2023). Kuderedza huwandu hwema calorie kunokuvadza masimba emuviri uye muviri wenyama, uye hazvina kuchengeteka kune vanhu vane kana vari mungozi yekutambura nechirwere chekudya, kana kune vanhu vakura vakawandisa.
Young mweya uye plasma exchange
Evident grade: yakatanga kana speculative
Panguva yekutenderera kwechidiki uye chidiki chemuromo, mamwe emativi emuromo wechidiki, senge mishonga neropa, anogadzirisa zvakanyanya (Conboy et al., 2005). Mumwe muropa protein, GDF11, yakakurumbira seyakareruka chikonzero, asi mushure mekushanda kwakawanda hakugone kuburitsa zviratidzo (Egerman et al., 2015). Vamwe vatsvakurudzi vanofunga kuti kubvisa zvinhu zvinokuvadza muropa rapfuura kunokosha kupfuura kuwedzera vanhu vatsva: muvanhu vekare, kungochinja hafu yeplasma nemvura uye albumin solution kwakawedzera mishonga yemishonga, impfa uye ubongo (Mehdipour et al., 2020). Mudiki placebo-yakadzorwa kuedza, zvakapetwa therapeutic plasma exchange (kuchinja plasma nemvura yealbumin) akashandura akawanda epigenetic maawa kuenda kune achiri mudiki makore (Fuentealba et al., 2025), uye mubvunzo muchirwere cheAlzheimer’s yakaderera kushushikana muzuva nezuva mabasa muvanhu vane zvishoma chirwere (Boada et al., 2020). Mu2019, US Food and Drug Administration yakazivisa vanhu kuti infusions yeplasma kubva kune vadiki vanopa havana “yakaratidza kliniki mhedzisiro” uye vanoisa matambudziko echokwadi (FDA, 2019).
Epigenetic clocks: kuongorora biological age
A kuongorora chirongwa, kwete kurapwa
Kuti vaone kana chero chinhu chichideredza kuora mwoyo, vanotsvakurudza vanoda nzira yekuiongorora pasina kumirira makore akawanda. Epigenetic clocks dzinoverenga makemikari emazita (methylation) mumazana enzvimbo paDNA uye dzinogona kufungidzira makore kubva pane zvakaita kuti munhu aite. Mumwe, wakaitwa naSteve Horvath, wakashanda nevanhu vane zvirwere zvakasiyana-siyana (Horvath, 2013; Hannum et al., 2013). Zvimwe zvinonzi zvakagadzirirwa kufungidzira hutano kupfuura makore: PhenoAge (Levine et al., 2018), GrimAge, iyo inofungidzira nguva kusvika pakufa (Lu et al., 2019), uye DunedinPACE, iyo inofungidzira kuti munhu ari kurarama sei, sespeedometer (Belsky et al., 2022). Vanhu vane maawa anofamba pamberi pemakore avo vanofa nekukurumidza panzvimbo yepakati (Chen et al., 2016).
Chii ivo havana kukwanisa kutaura isu: kana kudzoka kweawa kunoita munhu akasimba. Kurapa kungachinja zviratidzo pasina kuchinja biology pasi. Maawa anogonawo kunge ari muromo: iyo imwecheteyo muviri weropa wakaongororwa kaviri, akapa kudzidza kwemakore makumi manomwe kubva pakutanga, kunyangwe paine zvitsva zvakagadzirirwa kuti zviite kuti izvi zvive nyore (Higgins-Chen et al., 2022). Kuongororwa kwe “biological age” kunosiyana zvakanyanya uye hazvifanirwe kutungamira musarudzo dzechiremba.
Chii chinoratidzwa nhasi muvanhu
Evident grade: yakaratidza muvanhu
Pasinei nekuti dzidzo iri pamusoro yaramba ichikura, zvinokosha zvikuru kuti tirambe takasimba uye takachengeteka mumakore anotevera. Izvi zvinobva kumaitiro ehupenyu uye mishonga yakaongororwa nevakawanda vanhu. Hapana chekuzvidzosera kumashure, asi pamwe chete zvinotadza chirwere chemakore nemakore, uye zvakawanda zvezvo hazvina kudhura kana kuti hazvina kukwana.
Physical activity. The World Health Organization inokurudzira 150 kusvika 300 maminitsi ekushandisa zvakaringana, kana 75 kusvika 150 maminitsi ekushandisa zvakasimba, pavhiki, pamwe nekuwedzera miviri yemuromo pazuva rimwe kana kakawanda uye, kune vanhu vakura, kudzidziswa kwekudzora kuti varege kudonha. Kuita zvemitambo zvakadai sekurovedza muviri kunokonzera kuderera kwechirwere chemoyo, stroke, type 2 diabetes, zvimwe zvirwere zvemapapu, depression uye dementia (WHO, 2020). Kurovedza muviri kunosimudza miviri yevanhu vese.

Hausi kusvibisa. Vanhu vanodyara maoko pavanenge vaine makore 40 vane 90% yengozi shoma yekufa nekuda kwekuti vari kusimuka (Jha et al., 2013). Kudzima pazera chero ripi zvaro kunobatsira.
Blood pressure and cholesterol. Mu SPRINT trial, kudzora kweropa rakaderera kwakaderedza zviitiko zve cardiovascular uye kufa, uye kwakaderedza zvishoma zvinokuvadza zvekuziva (SPRINT MIND, 2019). Kukwira kweropa kunoitika kana chirwere cheshuga chichikwira zvakanyanya, uye kukwira kweropa kunokonzerwa nehurombo.

Diet. Mu PREDIMED trial, Mediterranean diets yakawedzera neolive oil kana nuts yakaderedza makuru e cardiovascular events neanenge 30 muzana zvichienzaniswa nekudya kwefashoni (Estruch et al., 2018). WHO inoti hapana huwandu hwealcohol hwakanaka kune hutano; zvishoma zviri nani.
Kurara. Vakuru vanokurudzira kuti varege kugara vachirara kwemazuva makumi matatu nemana pazuva (Watson et al., 2015); nguva refu yekuzorora kana kushungurudzwa kunokonzerwa nechirwere chemoyo uye chikafu, uye kushaya mwoyo panguva yekurara kuri kuitika kakawanda uye kunogona kurapwa.
Social connection. Mukuru meta-ongororo, vanhu nesimba zvikuru zvemagariro ukama aiita pamusoro 50 muzana kuwedzera kurarama pamusoro pemakore edzidzo (Holt-Lunstad et al., 2010).
Kunzwa, kuona uye zvirwere. Kushaya kuziva ndeimwe yezvikonzero zvikuru zvinochinja chirwere chehurema zvakaonekwa neLancet Commission, iyo inobatanidza 45% yevanhu vane hurema ne14 zvinhu zvinochinja (Livingston et al., 2024). Mubvunzo weACHIEVE, kuongororwa kwekunzwa kwakaderedza kuderera kwepfungwa ne48 muzana kupfuura makore matatu pakati pevanhu vakura vane hutano hwakanyanya (Lin et al., 2023). A zvakasikwa experiment mu Wales yakawana kuti shingles kuvharirwa yakaitwa neanenge 20 percent zvishoma dementia ongororo pamusoro pemakore gumi (Eyting et al., 2025).

Kana nzvimbo dzese dzichichinja. Zvimwe zvezvinhu zvakaomarara zvave kuitika kana vanhu vachichinja pamwe chete. In North Karelia, Finland, a region-wide programme from 1972 cut smoking, cholesterol and blood pressure, and deaths from coronary heart disease among people aged 35 to 64 fell by 82 percent in men and 84 percent in women by 2012 (Jousilahti et al., 2016; Puska et al., 2016). Mushure meScotland baned kusvibisa muzvivakwa zvakavharwa munyika yose muna 2006, hospital admissions for heart attacks and unstable angina yakaderera ne17 percent mugore rimwe chete (Pell et al., 2008). MuFinland FINGER trial, a two-year program of diet, exercise, brain training and vascular checks improved thinking and memory in people at risk of dementia (Ngandu et al., 2015), uye mu Taketoyo, Japan, vanhu vane makore akawanda vakatora chikamu munharaunda salons vaigona kurarama kwenguva yakareba kupfuura makore mana (Hikichi et al., 2015).
Iyo yakasimba kwazvo yekurarama kwenguva refu inoongororwa nguva dzose haina kudhura zvakanyanya: kutenderera, kugara, kusadya uye kugara uchibatanidza. Iyo nyowani science iine chinangwa chekuwedzera kune avo, kwete kuchinja ivo.
Mazuva akareba sei ekurarama nehutano angachinja huwandu hwevanhu
Iyo nyika iri kusangana nemamiriro ezvinhu anochinja munyaya dzezvematongerwo enyika ayo haasi kuitika kare. Sezvo United Nations inoti, huwandu hwevakadzi vanozvarwa pasi rose pari zvino huri pa2.25 emadzimai ese, zvichikwira kubva pa3.31 muna 1990; kupfuura hafu yenyika dzese nenzvimbo dzine huwandu hwevana hwaisvika pasi pe2.1, uye anenge mumwe muzana ane hukuru hwevana hwakaenzana kana kuti 1.4. Vanhu vepasi rose, 8.2 bhiriyoni muna 2024, vanofungidzirwa kuti vachasvika pa10.3 bhiriyoni mumidhudhudhu yemakore e2080 uye vazodzikira kusvika ku10.2 bhiriyoni muna 2100. Munyika nenzvimbo 63, dzinobata 28% yevanhu, huwandu hwevanhu hwasvika pakumuka. By the late 2070s, people aged 65 and over are projected to outnumber children under 18 (UN World Population Prospects 2024). Zvikonzero zvekuti kubereka kunodzikira, uye nei Local Solar System Foundation ichitsigira dzidzo nesarudzo dzakanaka dzese dzemhuri, zvinoratidzwa pawebhusaiti yedu ye vanhu, kushandiswa kwezvinhu uye zvinhu.
An older population is usually described as a burden: fewer workers supporting more retirees. The standard measure, the old-age dependency ratio, counts people aged 65 and over for every 100 people aged 20 to 64. Maererano nehuwandu hweUN, muna 2024 vanhu vepasi rose vaisvika pa18 uye zvinotarisirwa kuti vachasvika pa29 mu2050 uye pa44 mu2100; muJapan vanhu vacho vari pa55 (UN World Population Prospects 2024).
Kukura kwevanhu hakusi nhamba yakamira
Chiyero ichi chinoti munhu ane makore 65 ekuberekwa mu2100 achave nemakore 65 ekuberekwa sezvaaiita muna 1950. Demographers Warren Sanderson uye Sergei Scherbov vakapikisa kuti izvi zvinovhiringidza. Vachikurudzira kuongorora makore vanhu vakanga vasingagoni kurarama, kwete makore avo vakanga vagara, uye vakaratidza kuti vanhu vanogona “kukura vachiri vadiki” nekudaro kunyange zvazvo makore avo anenge ari pasi pemakore makumi maviri nemasere (Sanderson naScherbov, 2005; Sanderson naScherbov, 2010). Mumwe mufananidzo unoisa chiyero chemakore ekare apo kutarisirwa kwehupenyu hwakaremara kunosvika pasi pe15 makore: kune vechiFrench, iyo yaive 58 muna 1900 uye yakasvika 75 muna 2012 (Sanderson and Scherbov, 2015).
Chii chinonzi healthy. Pasirese, kutarisirwa kwehupenyu kwakakwira kubva pamakore 66.8 kusvika pamakore 73.1 pakati pe2000 ne2019, uye hukama pakati pekutarisirwa kwehupenyu uye kutarisirwa kwehupenyu hwakanaka hwakawedzera kubva pamakore 8.5 kusvika pamakore 9.6 (World Health Organization; Garmany neTerzic, 2024). Zviuru zvemakore anopfuura anorwadzwa nehutano hwakanaka anowedzera kumanikidza kwemhuri uye masystem ezvehutano. Zvimwe zviitiko zvehutano hwakanaka zvinosiyana: vanhu vanogona kuenderera mberi vachishanda kana vachida, kuchengeta vamwe, kuita basa rebasa repabonde, kudzidza uye kupa. Izvi ndizvo zvinoita kuti dzidzo yesainzi inowanikwa pawebhusaiti iyi ive nebasa rekubatsira vanhu, kwete chete kune munhu mumwe nemumwe.
Chinyorwa pamusoro ndechimwe chiratidzo, kwete tsananguro. Inoshandisa huwandu hwevanhu hwaitarisirwa neUN uye inoti: kana vanhu vakawana makore ehutano uye makore avo apo vanowanzo dzima basa uye vanoda rubatsiro rwakawanda akakwira pamwe navo, sei huremu hwakazochinja? Kana iyo mhirizhonga ichifamba kubva pa65 kusvika pa70, nyika ye2100 ichave nevanhu vanopfuura makore 31 ekuberekwa kune vese vanhu vane makore 100 ekuberekwa asi kwete 44; pa75, zvinenge 21, zvakaenzana nezvinoitika pari zvino. Zviri kufungidzirwa kuti zvichave zvakanaka, kuti basa nepensheni dzichachinja, uye kuti mhedzisiro ichasvika kune vese vanhu, kwete chete kune vakanaka.
Pashure, hutano hwevana
Vabereki vari kubereka vana vadiki zvakanyanya. Munyika dzeOECD, huwandu hwemakore emadzimai pavanenge vachizvarwa vasati varoora hwakwira kubva pa26.4 mu2000 kusvika pa29.6 mu2024 (OECD Family Database). The ovaries show marked ageing earlier than most other tissues in the body (Garrison, 2026), and declining fertility in the late thirties and forties limits how many children people who start later can have. Kuongorora kwepabonde kunoitwa negeroscience: semuenzaniso, VIBRANT trial yakaitwa kuColumbia University yakati inoratidza kuti sei kurapwa nerapamycin pazera rakareba rinogona kubatsirawo pakuderedza kushaya kwevakadzi vane makore 35 kusvika 45 (ClinicalTrials.gov NCT05836025); izvo zvinonzi zvakaitika hazvo hazvina kuburitswa. Kana kuzvarwa kwevana kuchigona kunonoka zvakachengeteka, vanhu vanoda vana vanogona kuvawana mushure memakore mashoma, pasina matambudziko ekuti vagare vachida.
Nei vakawanda demographers kutarisira kushushikana kuti kupera
Ichokwadi kuti zvinokosha kuva nechokwadi nezvekutaura kwakasiyana. Vaongorori veGlobal Burden of Disease vanofungidzira kuti 155 kubva ku204 nyika nenzvimbo dzichave nehuwandu hwevana hwaisvika pasi pekuchinja kwevanhu kusvika muna 2050 uye 198 kusvika muna 2100; kubva kumatunhu e47 uko huwandu hwevana hwawedzera, zvitatu chete zviri pamusoro pekuchinja kwevanhu (GBD 2021 Kubereka uye Kufungidzira Vatsigiri, 2024). The UN judges that countries with very low fertility whose populations have already peaked are highly unlikely to return to replacement within 30 years (UN World Population Prospects 2024). Vamwe demographers kuratidzwa anogona low-fertility trap, uko kushaya kwemakore akawanda, kushoma kwemhuri uye kushushikana kwezvehupfumi kunowedzerana (Lutz, Skirbekk uye Testa, 2006), uye vaongorori vezvehupfumi Dean Spears naMichael Geruso vanotaura kuti pasina kuchinja kwechirongwa, huwandu hwevanhu pasi rose huchadzikira kwenguva yakareba mushure mekusvika pakumutswa (Spears uye Geruso, 2025). Kurarama kwenguva yakareba kusingagadzirise dambudziko iri: zvinoderedza kuwedzera kwevanhu, asi munguva pfupi vanhu vane vana vashoma vanowedzera.
Isu hypothesis: kuderera ndechinguvana dambudziko
Local Solar System Foundation’s view is that population decline is a temporary problem, a transition to adapt to rather than a permanent crisis. Ticharatidza izvi sechirevo, nemamiriro edu uye nechokwadi chekuti zvinoratidza kuti zviri pachena kana zvisina.
Kufunga.
- Kurarama kwenguva yakareba nehutano kunoreva kuti kuzvarwa kuri pasi pehuwandu hwevanhu hwakakodzera kuti huve hwakachengeteka. Muhurombo hunoramba huripo, huwandu hwevanhu huchaenzana nehuwandu hwevanhu vanozvarwa pagore zvichienzaniswa nehuwandu hwevanhu vari kutarisirwa kurarama pavanenge vazvarwa, izvo zvinonzi demos (Preston, Heuveline and Guillot, 2001). Kana kutarisirwa kwehupenyu kuchikwira kubva pamakore 73 kusvika pamakore 90, vanhu vakafanana vanogona kuchengetwa nezana regumi nemasere emavambo mashoma pagore.
- Kuita tsvakurudzo yezvehutano, kwete makore, ndiko kuri kutungamira pakuziva kuti munhu anofanira kubatsirwa. Kana geroscience ichikwanisa kuderedza hutachiona hwemakore nemakore mashoma chete, huwandu hwevanhu vari kurarama vachida rubatsiro rwavo hucharamba huri pedyo nehuwandu hwevanhu vari munyika pari zvino, kunyange hazvo vanhu vachiwedzera kukura, sezvakaratidzwa mumifananidzo iri pamusoro apa.
- Kuita kuti vanhu vawane vana vakawanda kupfuura zvavanoda kunogona kubatsira. Kana kushaya mwana kuchikwanisa kunonoka, kurarama nemwana munguva pfupi hakusi kuzoreva kuti munhu anenge aine vana vashoma.
- Kuberekwa kwakadzokera kumashure Munyika dzakakura, dzimwe dzidzo dzakaona kuti kuenderera mberi kwekuvandudza kwaive kwakabatanidzwa nekuwedzera kweberekwa (Myrskylä, Kohler and Billari, 2009), kunyanya apo basa uye upenyu hwemhuri hwave nyore kubatanidza (Luci-Greulich and Thévenon, 2014), kunyangwe hazvo izvi zvakawanikwa zviri kukanganiswa (Harttgen and Vollmer, 2014).
- Kuderera kwakachena kunopa nguva yekuzvigadzirisa. UN inofungidzira kuti kukwira kuri kuomarara uye kudonha kwakanyanya kwechiuru ichi, kwete kupararira, izvo zvinosiya makore emakore ekuchinja kwesainzi, basa uye pfungwa dzemhuri.
Chii chingaita kuti zviongororwe? Mibvunzo iyi ichawana rutsigiro kana: kutarisirwa kwehupenyu hwakanaka kuchikwira nekukurumidza kupfuura kutarisirwa kwehupenyu, zvichivhara hukama; tsvakurudzo inoratidza kuti imwe nzira inoderedza hutachiona hwemakore akawanda panguva imwe chete, sezvakarongwa neTAME; kuzvarwa pazera rakakura kunowedzera zvakakwana kuti huwandu hwemhuri dziri kufara hausi kuderera; uye kufungidzira kwekuzvimirira kwevanhu vakura kwakatarisana nehutano, kwete nehurefu hwakavimbika, kunogara kuri nyore. Icharamba ichiderera kana kusiyana kwemakore ehutano kuchienderera mberi nekukura, kana kuedza kwekutanga kwevanhu kwerapamycin, senolytics uye reprogramming kukundikana, uye kana kubereka kuri kuramba kuchikwira kunyangwe paine vabereki vane makore marefu, hupenyu hwakanaka, rutsigiro rwakanaka uye sarudzo dzakanaka. Tichatevera chokwadi ichi uye tichagadzirisa iyi peji sezvakasvika.
Nhoroondo yenyika yevanhu vashoma, vane makore akawanda ekurarama inogonawo kuva nehupenyu hwakanaka panyika, uye ndiyo imwe yezvikonzero nei izvi zvichikosha mubasa re Local Solar System Foundation’s on balance between people and resources.
Ita shuwa: zvipfuwo, makliniki uye kuongorora kwemunhu
Masangano ari kuita izvi
Izvi zvirongwa zvisina kubhadharwa zvemari zvinoburitsa izvo zvavanoita uye zvinozivisa mikana yekuwana mari. Kana iwe uchida kutsigira hutano hwekukura, ndapota ona basa ravo uye funga nezvekupa kwavari zvakananga, kuburikidza newebhusaiti yavo. Local Solar System Foundation haina kumbova nehukama nadzo uye haisi kuwana chero chinhu kubva kwadzo. Pashure pekupa, verenga ongororo yegore negore uye mari dzese dzesangano.
- HelpAge International (United Kingdom, registered charity 288180). Works with partner organisations in many countries so that older people have access to health care, social care and income security, and speaks up for their rights.
- Age UK (United Kingdom, registered charity 1128267). Offers practical support to older people facing poverty, isolation and neglect, and researches and campaigns for better policy.
- British Heart Foundation (United Kingdom, registered charity 225971). Iyo yakakura kwazvo yakazvimirira inotsigira tsvakurudzo yemoyo uye kutenderera kwechirwere muUK.
- American Heart Association (United States, tax-exempt non-profit). Inopa mari yekutsvakurudza chirwere chemoyo nechirwere cheshuga uye inotungamira mapurojekiti evanhu ekuzvidzivirira.
- Alzheimer’s Society (United Kingdom, yakanyorwa chirongwa chekubatsira 296645) uye the Alzheimer’s Association (United States, tax-exempt non-profit). Vaviri ava vanotsigira vanhu vari kurwara nehurema uye avo vanorwira, uye vanopa mari yekutsvakurudza kuderedza chirwere ichi, kurapwa kwayo uye kuchengetwa kwevanhu.
Maitiro ekubatsira
- Tarisa zvazvinoita. Teerera kuvanhu vako, wedzerawo zvekurovedza muviri uye uwane chiremba kuti akuongorore chirwere cheropa.
- Test kunzwa kwako uye maziso ako, uye kurudzira vabereki vako kuti vaitewo izvi.
- Kuramba uchitaura. Nhare munhu wawakataura naye kwenguva yakareba; kumbira mumwe mugari kuti aite chimwe chinhu.
- Follow the trials, not the ads. Zvibodzwa kubva kuongororo dzakanyorwa, dzakaburitswa mumagazeti akaongororwa nevaverengi, ndizvo zvinokosha.
- Kuzviona sekuti hauna kutenda mumidzimu, uye shandisa kugovera iyi peji kana ukaona imwe.
- Tibatsire kuti iyi peji irambe yakakodzera. Vatsvakurudzi, vaongorori vezvehutano uye vanoshandura vanogona kushandira sevanozvipira pacontribution board.
Zvimwe zvinokosha zvekuverenga
- Kennedy et al. (2014), Geroscience: kubatanidza aging kune chronic disease, Cell 159
- López-Otín et al. (2013), Zviratidzo zvekukura, Cell 153
- López-Otín et al. (2023), Hallmarks of aging: an expanding universe, Cell 186
- Goldman et al. (2013), Kuzvipira kwehutano uye kudzoka kwehupfumi kubva pakunonoka aging zvinogona kutungamira kune nyowani yekutsvakurudza yechiremba, * Health Affairs * 32
- Scott, Ellison uye Sinclair (2021), Iyi ndeyehupfumi hwekutarisisa kuzvarwa, Nature Aging 1
- US National Center for Health Statistics (2026), NHIS Adult Summary Health Statistics, 2025, and the NHIS 2025 sample adult file
- US National Cancer Institute, SEER*Explorer, kupararira kwechirwere chegomarara zvichienderana nezera, 2019 to 2023
- Manly et al. (2022), Kufungidzira kupararira kwedementia uye yakaderera yekuziva kukanganisa muUS, JAMA Neurology 79
- Garmany and Terzic (2024), Global healthspan-lifespan gaps among 183 World Health Organization member states, JAMA Network Open 7
- US National Institute on Aging, Interventions Testing Program
- Vézina, Kudelski uye Sehgal (1975), Rapamycin (AY-22,989), a new antifungal antibiotic, Journal of Antibiotics 28
- Harrison et al. (2009), Rapamycin yakapihwa muhupenyu hwakareba hunowedzera hupenyu hwevanhu mune zvakasiyana-siyana zvirwere zvemaziso, Nature 460
- Miller et al. (2011), Rapamycin, asi kwete resveratrol kana simvastatin, inowedzera hupenyu hwehupenyu hwezvirwere zvepabonde zvakasiyana-siyana, * Journals of Gerontology A * 66
- Miller et al. (2014), Rapamycin-inokonzerwa nehupenyu hwehupenyu hwehupenyu mumidzi ndeye dosage uye sex dependent, * Aging Cell * 13
- Mannick et al. (2014), mTOR inhibition inovandudza immune function muvanhu vakura, * Science Translational Medicine * 6
- Mannick et al. (2018), TORC1 inhibition inowedzera immune function uye inoderedza hutachiona muvanhu vane makore anopfuura makumi maviri nemana, * Science Translational Medicine * 10
- Mannick et al. (2021), Kutarisana nebiology yekuzvarwa ne mTOR inhibitors kuti uvandudze hutano hwemuviri muvanhu vakura: phase 2b uye phase 3 randomized trials, Lancet Hupenyu hwakanaka 2
- Moel et al. (2025), Kukonzerwa kwerapamycin pahutano hwehutano uye metrics mushure megore rimwe chete: PEARL trial results, * Aging * 17
- Lee, Kuerec uye Maier (2024), [Kutarisana nekurasika kwerapamycin neyakagadzirwa kwayo muvanhu: kuongororwa kwaka systematic](https://doi.org/10.1016/S2666-7568(23) 00258-1), Lancet Healthy Longevity 5
- Lamming et al. (2012), Rapamycin-inokonzerwa neinsulin resistance inokonzerwa ne mTORC2 kupera uye yakaenzana nehupenyu, * Science * 335
- National Library of Medicine, DailyMed: sirolimus prescribing information
- Coppé et al. (2008), Senescence-inobatanidza secretory phenotypes inoburitsa cell-non-autonomous mabasa eoncogenic RAS uye p53 tumor suppressor, * PLOS Biology * 6
- Baker et al. (2011), Kubvisa kwep16Ink4a-positive senescent cells kunokanganisa chirwere chekukura, Nature 479
- Baker et al. (2016), Naturally kuitika p16Ink4a-positive muviri anoderedza upenyu hwakanaka, * Nature * 530
- Zhu et al. (2015), The Achilles’ heel yesenescent cells: kubva kutranscriptome kusvika kune senolytic drugs, * Aging Cell * 14
- Xu et al. (2018), Senolytics kuvandudza chimiro chemuviri uye kuderedza huremu hwehupenyu mumakore apfuura, Nature Medicine 24
- Yousefzadeh et al. (2018), Fisetin ndeye senotherapeutic iyo inowedzera hutano uye hurefu hwehupenyu, * EBioMedicine * 36
- Justice et al. (2019), Senolytics muidiopathic pulmonary fibrosis: zviratidzo kubva pakutanga-mumunhu, open-label, pilot study, * EBioMedicine * 40
- Hickson et al. (2019), Senolytics inoderedza senescent cells muvanhu, * EBioMedicine * 47
- Farr et al. (2024), Mashandisiro eiyo intermittent senolytic therapy pamuviri wenyama muvakadzi vasati vambopedza menopause: phase 2 randomized controlled trial, * Nature Medicine * 30
- Gonzales et al. (2023), Senolytic therapy muhurombo hweAlzheimer’s: phase 1 kuedza kwekuita, * Nature Medicine * 29
- Unity Biotechnology (2025), ASPIRE phase 2b topline results and certificate of dissolution, US Securities and Exchange Commission filings
- Mills et al. (2016), Kutora kwechinguvana kwenicotinamide mononucleotide kunoderedza makore anokonzerwa nefiziological kuderera mumidzi, Cell Metabolism 24
- Zhang et al. (2016), NAD + kupfupisa kunovandudza mitochondrial uye stem cell functional uye kunowedzera huremu hwehupenyu mumazino, * Science * 352
- Harrison et al. (2021), 17-a-estradiol yakadzikira muhupenyu inowedzera hupenyu hwehupenyu mune zvinokura UM-HET3 mukadzi maziso; nicotinamide riboside uye matatu mamwe majekiseni haagumire hupenyu hwehupenyu mune chero chiito, * Aging Cell * 20
- Martens et al. (2018), Chronic nicotinamide riboside supplementation inotonhorera zvakanaka uye inowedzera NAD + muhutano hwevanhu vane makore makumi maviri nemana nemakumi masere nemashanu nematanhatu, Nature Communications 9
- Yoshino et al. (2021), Nicotinamide mononucleotide inowedzera kugadzikana kweinsulin yemishonga muvarume vane prediabetic, * Science * 372
- Brakedal et al. (2022), Studio NADPARK: yakaenzana-yakaenzana phase I yekuongorora nicotinamide riboside supplementation muchirwere cheParkinson’s, Cell Metabolism 34
- Zhang et al. (2025), Kushanda kweiyo oral nicotinamide mononucleotide supplementation paglucose uye lipid metabolism yevakuru: systemic review, * Critical Reviews muFood Science and Nutrition * 65
- Prokopidis et al. (2025), Mhinduro yenicotinamide mononucleotide uye riboside paskeletal muscle mass uye basa, * Jornal de Cachexia, Sarcopenia e Muscle * 16
- US Food and Drug Administration (2025), kudzokera kune mutongo wevagari paNMN, docket FDA-2023-P-0872
- Howitz et al. (2003), Chidiki molekitori activators yesirutins inowedzera Saccharomyces cerevisiae hupenyu, * Nature * 425
- Baur et al. (2006), Resveratrol inovandudza hutano uye kurarama kwemazino pakudya kwakakwirira-calorie, * Nature * 444
- Pearson et al. (2008), Resveratrol inononoka kuora kwemakore uye inofananidza transcriptional maficha ekudya zvinorambidzwa pasina kusimudzira hupenyu hwehupenyu, * Cell Metabolism * 8
- Kaeberlein et al. (2005), Substrate-inokosha kumisikidza sirtuins ne resveratrol, * Jornal of Biological Chemistry * 280
- Pacholec et al. (2010), SRT1720, SRT2183, SRT1460, uye resveratrol hazvisi zvakananga activators of SIRT1, * Jornal de Biológica Chemia * 285
- Burnett et al. (2011), Kusawanikwa kwemhedzisiro yeSir2 overexpression pahupenyu hwehupenyu muC. elegans neDrosophila, Nature 477
- GlaxoSmithKline and Sirtris Pharmaceuticals (2008), tender offer statement, US Securities and Exchange Commission
- Kanfi et al. (2012), The sirtuin SIRT6 inodzora hupenyu hwehupenyu muvakadzi maziso, * Nature * 483
- Roichman et al. (2021), Kudzoreredza kwehomeostasis yesimba neSIRT6 kunowedzera hupenyu hwakanaka, Nature Communications 12
- Mubairo weNobel muPhysiology kana Medicine 2009 uye 2012
- Bernardes de Jesus et al. (2012), Telomerase gene therapy muvakuru uye vanhu vadiki midzi inoderedza kuora mwoyo uye inowedzera hurefu hwehupenyu pasina kuwedzera chirwere, * EMBO Molecular Medicine * 4
- Kim et al. (1994), Specific mubatanidzwa wevanhu telomerase chiitiko neimba yenyama uye cancer, * Science * 266
- Telomeres Mendelian Randomization Collaboration, Haycock et al. (2017), Kubatanidzwa pakati petelomeres uye njodzi yechirwere chegomarara nehutano hwemagariro, JAMA Oncology 3
- Armanios naBlackburn (2012), The telomere syndromes, Nature Reviews Genetics 13
- Townsley et al. (2016), Danazol kurapa kwechirwere chetelomere, NEJM 374
- Takahashi naYamanaka (2006), Kusimudzira kwe pluripotent stem cells kubva kumamiriro ezvinhu ematombo ematanda uye emafibroblasts neakanyatsojeka maficha, Cell 126
- Ocampo et al. (2016), In vivo amelioration yemakore anobatanidza mavara ne partial reprogramming, * Cell * 167
- Lu et al. (2020), Kugadziridza kudzoreredza yechidiki epigenetic ruzivo uye kudzoreredza kuona, Nature 588
- Browder et al. (2022), In vivo yakateedzana reprogramming inoshandura makore anobatanidza molekitori shanduko panguva yephysiological kuora kwevanhu mumishonga, * Nature Aging * 2
- Macip et al. (2024), Gene therapy-mediated partial reprogramming inowedzera hurefu hwehupenyu uye inodzosera kuchinja kwemakore muvakadzi, * Cellular Reprogramming * 26
- Abad et al. (2013), Reprogramming in vivo inogadzira teratomas uye iPS cells netotipotency features, * Nature * 502
- Parras et al. (2023), In vivo reprogramming inotungamira mukufa kwakapfuura kunoenderana nehuremu hwepanyama uye nekukasira kwechiropa, * Nature Aging * 3
- Life Biosciences (2026), FDA kubvumidzwa kweIND yeER-100 uye kutanga munhu akapihwa; ongororo yekunyora NCT07290244
- Kutaura kwekambani: Altos Labs (2022), Retro Biosciences (2026), NewLimit (2026); uye MIT Technology Review (2023) paRetro Biosciences
- Jiang et al. (2025), ongororo yeInterventions Testing Program, Journals of Gerontology A 80
- Harrison et al. (2014), Acarbose, 17-α-estradiol, uye nordihydroguaiaretic acid inowedzera nguva yehupenyu hwemuromo zvakananga muvakadzi, * Aging Cell * 13
- Strong et al. (2016), Kukura kwehupenyu muvakadzi midzi yakagadziriswa neyakaderera estrogenic agonist, antioxidant, α-glucosidase inhibitor kana Nrf2-inducer, * Aging Cell * 15
- Strong et al. (2008), Nordihydroguaiaretic acid uye aspirin kuwedzera huremu hwehupenyu hwegenetiki heterogeneous male midzi, * Aging Cell * 7
- Miller et al. (2019), Glycine supplementation inowedzera hupenyu hwevarume nevakadzi midzi, * Aging Cell * 18
- Miller et al. (2020), Canagliflozin inowedzera hupenyu hwehupenyu mugenetiki heterogeneous men’s asi kwete female mouse, JCI Insight 5
- Strong et al. (2022), Kuchengetedzwa kwehupenyu hwekubatanidza rapamycin plus acarbose uye captopril mugenetiki heterogeneous midzi, * Aging Cell * 21
- Bannister et al. (2014), Vanogona vanhu vane Type 2 Diabetes kurarama kwenguva yakareba kupfuura avo vasina?, Diabetes, Obesity and Metabolism 16
- Barzilai et al. (2016), Metformin sechinhu chekutungamira aging, Cell Metabolism 23
- Mazita et al. (2022), Kuongororazve chokwadi chekurarama kwehutano hwechirwere cheshuga chine chirwere cheshuga chemhando 2 chakagadziriswa ne metformin zvichienzaniswa nekudzora pasina chirwere cheshuga, * International Journal of Epidemiology * 51
- Konopka et al. (2019), Metformin inhibites mitochondrial adaptation to aerobic exercise training in older adults, * Aging Cell * 18
- Walton et al. (2019), Metformin inodzikira mishonga yechiropa semhedzisiro yekuenderera mberi kwesimba rekurovedza muviri muvanhu vakura (MASTERS), * Aging Cell * 18
- Lincoff et al. (2023), Semaglutide uye cardiovascular zviratidzo muhurema hwepanyama pasina chirwere cheshuga (SELECT), NEJM 389
- Xie, Choi uye Al-Aly (2025), Kuongorora kushanda uye matambudziko eGLP-1 receptor agonists, Nature Medicine 31
- Cummings et al. (2026), [Oral semaglutide mukutanga kwechirwere cheAlzheimer’s (evoke uye evoke +)](https://doi.org/10.1016/S0140-6736(26) 00459-9), The Lancet 407
- Mattison et al. (2017), Kurambidzwa kwecalorie kunovandudza hutano uye kurarama kwerhesi monkeys, Nature Communications 8
- Kraus et al. (2019), 2 makore ekudya kwekalori uye chirwere che cardiometabolic (CALERIE), Lancet Diabetes & Endocrinology 7
- Waziry et al. (2023), Kukanganisa kwenguva refu yekudya kwemafuta ezuva paDNA methylation zviyero zvebiological aging, Nature Aging 3
- Conboy et al. (2005), Rejuvenation yemakore apfuura progenitor cells nekuvapo kwechidiki systemic nharaunda, * Nature * 433
- Mehdipour et al. (2020), Kudzokorora kwezvidimbu zvemativi matatu ezvigadzirwa nekuchinjana kweropa rakaoma nemvura yemushonga-albumin, * Kukura * 12
- Egerman et al. (2015), GDF11 inowedzera nemakore uye inhibites skeletal muscle regeneration, Cell Metabolism 22
- Fuentealba et al. (2025), Multi-omics ongororo inoratidza biomarkers iyo inowedzera kuhupenyu hwehupenyu hwehupenyu semhedzisiro yekurapa kweplasma exchange, * Aging Cell * 24
- Boada et al. (2020), Randomized, yakadzora kliniki yekuyedza kwe plasma exchange nealbumin replacement yechirwere cheAlzheimer’s (AMBAR), *Alzheimer’s & Dementia * 16
- US Food and Drug Administration (2019), Chirevo chinokurudzira vatengesi kuti varege kugamuchira plasma inopihwa nevadiki
- Horvath (2013), DNA methylation makore evanhu tishu uye cell types, * Genome Biology * 14
- Hannum et al. (2013), Genome-wide methylation profiles inoburitsa huwandu hwekuona kwevanhu vane chirwere chehutano, * Molecular Cell * 49
- Levine et al. (2018), Epigenetic biomarker yekurara kwehupenyu hwehupenyu uye hutano (PhenoAge), *Kukura * 10
- Lu et al. (2019), DNA methylation GrimAge yakanyatso kufungidzira hurefu hwehupenyu uye hutano, Kukura kwevakuru 11
- Belsky et al. (2022), DunedinPACE, a DNA methylation biomarker yenguva yekukura, eLife 11
- Chen et al. (2016), DNA methylation-based zviyero zvebiological makore: meta-ongororo inofungidzira nguva yekufa, * Aging * 8
- Higgins-Chen et al. (2022), Computational solution yekuwedzera kuvimbika kweepigenetic clocks, Nature Aging 2
- World Health Organization (2020), Maitiro ekuita zvemitambo uye kugara uchirara
- Jha et al. (2013), 21st- century madhara ekushaikwa kweropa uye mibairo yekubvisa muUnited States, NEJM 368
- SPRINT MIND Vaongorori (2019), Effect of intensive vs standard blood pressure control on probable dementia, JAMA 321
- Estruch et al. (2018), Kudzivirirwa kwekutanga kwechirwere che cardiovascular ne Mediterranean diets, NEJM 378
- Watson et al. (2015), Recommended amount of sleep for a healthy adult, Sleep 38
- Holt-Lunstad et al. (2010), Kuita zvepabonde uye chirwere chekufa, PLOS Medicine 7
- Livingston et al. (2024), Kudzivirirwa kwedementia, kuongororwa uye kurapwa: 2024 report yeLancet standing Commission, The Lancet 404
- Lin et al. (2023), Kunzwa ku intervene versus kudzora kwehutano hwedzidzo kuti urege kuderedza kudzidza kuderera (ACHIEVE), * The Lancet * 402
- Eyting et al. (2025), A natural experiment on the effect of herpes zoster vaccination on dementia, Nature
- Paluch et al. (2022), [Dzimba dzezuva nezuva uye kufa kwese: meta-ongororo ye15 international cohorts](https://doi.org/10.1016/S2468-2667(21) 00302-9), The Lancet Public Health 7
- Jousilahti et al. (2016), 40-year CHD mortality trends uye basa rezvikonzero zvehutano hwehutachiona mukufa kwevanhu: ruzivo rweNorth Karelia Project, Global Heart 11
- Puska et al. (2016), Kubva pakutanga, zvinangwa, kutevedzera uye ruzivo rweNorth Karelia Project, Global Heart 11
- Vartiainen et al. (2010), Thirty-five-year trends in cardiovascular risk factors in Finland, * International Journal of Epidemiology * 39
- Pell et al. (2008), Smoke-free zvibvumirano uye hospitalizations yeacute coronary syndrome, * NEJM * 359
- Ngandu et al. (2015), A 2 gore multidomain kukonzera kuti zvidzivirire kudzidza kushushikana muvanhu vane hutachiona vanhu (FINGER), * The Lancet * 385
- Hikichi et al. (2015), Effect of a community intervention program promoting social interactions on functional disability prevention for older adults: the JAGES Taketoyo study, Journal of Epidemiology and Community Health 69
- United Nations, Department of Economic and Social Affairs, Population Division (2024), World Population Prospects 2024: Summary of Results (PDF) uye data mafaera
- Sanderson naScherbov (2005), Mutengo wakawandisa wehupenyu hunoramba huchiwedzera sevanhu vachikura, Nature 435
- Sanderson naScherbov (2010), Remeasuring aging, * Science * 329
- Sanderson naScherbov (2015), Kuwedzera kwehupenyu hwevanhu kunokonzeresa kuderera kwevanhu vane makore, PLOS ONE 10
- World Health Organization, Global Health Observatory: life expectancy and healthy life expectancy
- OECD Family Database, Age of mothers at childbirth and age-specific fertility
- Garrison (2026), Kune kure nekubereka: ovary sesystemic regulator yehutano hwemukadzi uye aging, PLOS Biology 24
- VIBRANT study of rapamycin and ovarian aging, ClinicalTrials.gov NCT05836025
- GBD 2021 Fertility and Forecasting Collaborators (2024), Kuberekwa kwepasi rose mu204 nyika nenzvimbo, 1950 kusvika 2021, nematanho egore ra2100, The Lancet 403
- Lutz, Skirbekk and Testa (2006), The low-fertility trap hypothesis, Vienna Yearbook of Population Research
- Spears uye Geruso (2025), mushure meSpike: Vanhu, Kubudirira, uye Case for People, Simon & Schuster
- Preston, Heuveline and Guillot (2001), Demography: Kuongorora uye Kugadzira Maitiro eVashandi, Blackwell
- Myrskylä, Kohler and Billari (2009), Kuvandudzwa kwehutano kunoderedza kushaya mimba, Nature 460
- Luci-Greulich and Thévenon (2014), Does economic advancement ‘cause’ a re-increase in fertility?, European Journal of Population 30
- Harttgen naVollmer (2014), Kuchinja muhukama hwekusimudzira kwevanhu nehuwandu hwevana vanozvarwa?, Demography 51
- MIT Technology Review (2015), 2015 mubiomedicine
- Kubatsira zvinyorwa kubva ku Charity Commission for England and Wales register uye US kwete-profit status kubva ku ProPublica Nonprofit Explorer